Caris Life Sciences, Inc. (CAI)

Caris Life Sciences Stock Forecast

Stock Price Forecast

The 9 analysts that cover Caris Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $32.33, which forecasts a 65.71% increase in the stock price over the next year. The lowest target is $22 and the highest is $42.

Price Target: $32.33 (+65.71%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$22	$32.33	$32	$42
Change	+12.76%	+65.71%	+64.02%	+115.27%

Analyst Ratings

The average analyst rating for Caris Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	4	4	4
Buy	3	3	3	4	4	4
Hold	0	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	7	7	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vijay Kumar Evercore ISI Group	Evercore ISI Group	Buy Maintains $34 → $30	Buy	Maintains	$34 → $30	+53.77%	Apr 6, 2026
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Hold Maintains $30 → $22	Hold	Maintains	$30 → $22	+12.76%	Mar 13, 2026
Vijay Kumar Evercore ISI Group	Evercore ISI Group	Buy Maintains $38 → $34	Buy	Maintains	$38 → $34	+74.27%	Feb 27, 2026
Catherine Schulte Baird	Baird	Buy Maintains $26 → $28	Buy	Maintains	$26 → $28	+43.52%	Feb 27, 2026
Mark Massaro BTIG	BTIG	Strong Buy Maintains $45 → $38	Strong Buy	Maintains	$45 → $38	+94.77%	Feb 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.02B

Increased by 25.24%

from 812.03M

Revenue Next Year

1.25B

Increased by 22.52%

from 1.02B

EPS This Year

0.19

from -3.22

EPS Next Year

0.39

Increased by 100.91%

from 0.19

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	258.49M	306.13M	412.26M	812.03M	1.02B	1.25B	1.46B
Revenue Growth	-	18.43%	34.67%	96.97%	25.24%	22.52%	17.50%
EPS	-11.98	-13.24	-10.66	-3.22	0.19	0.39	0.65
EPS Growth	-	-	-	-	-	100.91%	68.46%
Forward PE	-	-	-	-	101.25	50.40	29.92
No. Analysts	-	-	-	-	12	12	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	1.1B	1.4B
Avg	1.0B	1.2B
Low	980.0M	1.2B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	30.9%	33.2%
Avg	25.2%	22.5%
Low	20.7%	13.9%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	0.48	0.56
Avg	0.19	0.39
Low	0.05	0.14

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	188.8%
Avg	-	100.9%
Low	-	-28.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.